Holly L Deak

This inventor holds 10 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 7 EPO patents. Top assignee: Amgen Inc.. Active years: 2010-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Holly L Deak. Retrieved from https://idiyas.com/inventor/holly-l-deak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 10 (Patent Applications = 2)

% Patents Active = 80.0

CIPO Patents = 3

EPO Patents = 7 (Patent Applications = 4)

Average Co-Inventor Count = 10.7

ph-index = 6

Forward Citations = 70(Granted Patents)

Company Filing History:

10 out of 2,076

Amgen Inc.

patents

Years Active: 2010-2017

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9776995 - Bicyclic sulfonamide compounds as sodium channel inhibitors (2017-10-03),

2. 9126935 - Aurora kinase modulators and methods of use (2015-09-08),

3. 9012443 - Bicyclic aryl and heteroaryl sodium channel inhibitors (2015-04-21),

4. 8476434 - Protein kinase modulators and method of use (2013-07-02),

5. 8415376 - Inhibitors of PI3 kinase (2013-04-09),

6. 8022221 - Aurora kinase modulators and method of use (2011-09-20),

7. 7981891 - Aurora kinase modulators and method of use (2011-07-19),

8. 7880000 - Protein kinase modulators and method of use (2011-02-01),

9. 7868177 - Multi-cyclic compounds and method of use (2011-01-11),

10. 7776857 - Aurora kinase modulators and method of use (2010-08-17),

Title: Exploring the Innovations of Inventor Holly L Deak

Introduction

Holly L Deak, a talented inventor based in Brookline, MA (US), has made significant contributions to the field of pharmaceuticals with her inventive spirit and dedication to scientific excellence.

Latest Patents

Deak's latest patents showcase her prowess in developing cutting-edge pharmaceutical compounds. One of her notable inventions includes "Bicyclic sulfonamide compounds as sodium channel inhibitors," targeting voltage-gated sodium channels like Nav1.7 for the treatment of pain disorders. Additionally, she has patented "Aurora kinase modulators and methods of use," demonstrating the potential to influence cell cycle processes to combat cancer and related diseases.

Career Highlights

With an impressive portfolio of 10 patents to her name, Deak has established herself as a leading innovator in the pharmaceutical industry. Her relentless pursuit of novel solutions has led to the development of groundbreaking therapies that have the potential to revolutionize medical treatments.

Collaborations

Deak's collaborative work at Amgen Inc. has been instrumental in driving innovation and pushing the boundaries of pharmaceutical research. Working alongside accomplished coworkers like Hanh Nho Nguyen and Brian Lewis Hodous, she has fostered a culture of creativity and excellence within the company.

Conclusion

Inventor Holly L Deak's remarkable journey is a testament to her unwavering commitment to advancing scientific knowledge and improving healthcare outcomes. Her innovative patents reflect a deep understanding of complex biological processes and a passion for developing novel therapies that can make a difference in patients' lives.

Profile summary based on public USPTO records.